Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yanyin
Contact Yanyin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Transitioning from efgartigimod to tacrolimus in chronic inflammatory demyelinating polyneuropathy: a prospective case series
Abstract To describe the clinical outcomes of transitioning from efgartigimod to tacrolimus in chronic inflammatory demyelinating polyneuropathy (CIDP) patients. Six patients who completed the ADHERE trial and maintained clinical stability during the open-label extension phase (≥30 weeks of weekly efgartigimod) were transitioned to oral tacrolimus following efgartigimod discontinuation and were followed at 3-month intervals for 12 months.
Journal of the Peripheral Nervous System | PNS Neuroscience Journal | Wiley Online Library
DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Yanyin
Contact Yanyin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack